Auckland, New Zealand – November 12, 2025 – Alimetry, a leader in gastrointestinal diagnostics and digital health announced the appointment of Karen O'Regan as its new Chief Business Officer effective October 30th.
O'Regan joins the executive team, bringing over 25 years of international expertise in strategic partnerships, digital innovation, and scaling global operations across diverse sectors including technology, retail, and healthcare.
O’Regan is a proven senior leader renowned for transforming vision into high-growth businesses. Her career has been defined by successfully negotiating and executing high-value deals with global industry giants, including Tesco, Best Buy, Boots, Bayer, Apple, and the NHS. Her appointment is a pivotal step in accelerating Alimetry's strategic expansion into the US market and to solidify growth in the UK and Australasia.
"Karen's exceptional track record of delivering transformative growth across major international markets makes her the ideal leader to accelerate our international ambitions and cement our emerging leadership in non-invasive diagnostics," said Greg O’Grady, Alimetry CEO and Co-Founder. "Her deep background in healthcare, sales and technology, coupled with her deep knowledge of data analytics, provides a unique skill set critical to our next phase of scaling."
Throughout her career, O'Regan has led teams in expanding operations across North America, Europe, Asia, and New Zealand, consistently improving business efficiency and driving significant revenue gains. Her core skills encompass innovation and transformation delivery, strategic joint ventures, and general management, underscoring her ability to navigate complex business landscapes.
"I am thrilled to join Alimetry at such a dynamic time," said Karen O'Regan. "The opportunity to unlock new growth potential for the company is incredibly exciting. I look forward to collaborating with the team to expand our global footprint and deliver high-impact solutions to our clients worldwide."
About Gastric Alimetry
The Gastric Alimetry test measures gastric electrophysiology non-invasively in a clinical setting. Recordings are taken before and after a standard meal, while patients simultaneously log their symptoms into the Gastric Alimetry App. The system performs a high-resolution recording of digestive patterns from the skin surface and delivers clinical reports via the cloud to inform the diagnosis of gastric diseases and support personalized therapy. The Gastric Alimetry system is indicated as an aid to diagnosis of various gastric disorders, including functional dyspepsia, gastroparesis and chronic nausea and vomiting disorders, which affect >10% of the US population and impact billions of dollars in healthcare expenses.
About Alimetry
Alimetry is a MedTech and digital health start-up focused on improving the care of patients with chronic gastrointestinal symptoms. Spun out of the University of Auckland in 2019 from a centre of excellence in digestive diseases, the company was founded by Professor Greg O’Grady (CEO) and Dr. Armen Gharibans (CTO, VP of US), leveraging a decade of award-winning science. Alimetry is dedicated to advancing gastrointestinal health through innovative diagnostic solutions, aiming to enhance the quality of life for patients worldwide.
For more information see www.alimetry.com
Media Contact:
Vasey Hargreaves, Head of Marketing
vasey.hargreaves@alimetry.com
